TrialCritical care (London, England)2024

Imatinib treatment improves hyperglycaemic dysregulation in severe COVID-19: a secondary analysis of blood biomarkers in a randomised controlled trial.

Erik Duijvelaar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.